Jul 19, 2021

Dr. Ryan Mathis is the Vice President of Commercial Strategy at PolarityTE, focusing on bringing regenerative medicine into clinical practice, particularly for treating diabetic foot ulcers and other forms of complex wounds.

Ryan says, "So, we're trying to solve this problem by developing SkinTE, which is...

Jul 19, 2021

Dr. Ryan Mathis is the Vice President of Commercial Strategy at PolarityTE, focusing on bringing regenerative medicine into clinical practice, particularly for treating diabetic foot ulcers and other forms of complex wounds.

Ryan says, "So, we're trying to solve this problem by developing SkinTE, which is...

Jun 2, 2020

Dr. George Shapiro, Chief Medical Officer, Organicell describes the regenerative medicine challenges to regenerate tissue and avoid surgery in patients.  Organicall is using extracellular vesicles and perinatal derived nano-particles from amniotic fluid taken in the operating room from planned C-section US births. Their...

Jun 2, 2020

Dr. George Shapiro, Chief Medical Officer, Organicell describes the regenerative medicine challenges to regenerate tissue and avoid surgery in patients.  Organicall is using extracellular vesicles and perinatal derived nano-particles from amniotic fluid taken in the operating room from planned C-section US births. Their...

Mar 10, 2020

Dr. Gil Van Bokkelen, founder and CEO, Athersys a clinical stage biotech company, talks about developing cell therapies and regenerative medicine as alternatives to conventional standards of medical intervention and treatment using their MultiStem cell therapy platform.  Gil explains how cell therapies work by providing...